Brucke Financial, Inc.

Position in GILD — Gilead Sciences, Inc.

CIK 2058446 INDIANAPOLIS, IN

Position in GILD

as of Jun 30, 2026 · filed Jul 21, 2026 Compact

Position Value

$311,175

-$38,364 QoQ

Shares Held

2,463

-1.8% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.29%

of 13F equity value

Holder Rank

#1,626

of 2,266 holders

Holding Since

Mar 2025

6 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Brucke Financial, Inc. holds $4,830,124 across 6 Drug Manufacturers - General names. GILD ranks #6 (6.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	1,197	$1,435,717
2	JNJ	Johnson & Johnson	4,299	$1,091,817
3	MRK	Merck & Co., Inc.	6,337	$814,304
4	ABBV	AbbVie Inc.	2,810	$707,108
5	NVS	Novartis AG	2,999	$470,003
6	GILD	Gilead Sciences, Inc. This page	2,463	$311,175

6 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$311,175	2,463	-1.8%	Shares	Sole	2026-07-21
2026-03-31	$349,539	2,508	-22.2%	Shares	Sole	2026-04-10
2025-12-31	$395,468	3,222	-8.5%	Shares	Sole	2026-01-12
2025-09-30	$391,053	3,523	-2.4%	Shares	Sole	2025-11-12
2025-06-30	$400,351	3,611	+57.8%	Shares	Sole	2025-07-24
2025-03-31	$256,482	2,289	—	Shares	Sole	2025-05-08
No filing history on record for this holder in this stock.